Infectious Disease
HPV Vaccination
0
Pipeline Programs↗
8
Active Trials↗
0
Companies Involved↗
HPV Vaccination is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
25
clinical trials
Completed12 · 48%
Unknown status4 · 16%
Active, not recruiting3 · 12%
Not yet recruiting3 · 12%
Recruiting2 · 8%
Terminated1 · 4%
Clinical Trials
Trial Activity
25 trials
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
Recruiting·ZZhejiang Provincial Center for Disease Control and Prevention·Phase 4·NCT07281677·400 enrolled
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Active, not recruiting·—·Phase 4·NCT04206813·352 enrolled
Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania
Active, not recruiting·LLondon School of Hygiene and Tropical Medicine·Phase 4·NCT04953130·10,400 enrolled
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Completed·—·Phase 4·NCT04982614·1,403 enrolled
The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
Completed·—·N/A·NCT06258564·12,000 enrolled
Effect of HPV Vaccination on Women Aged 25 Years
Completed·—·Phase 4·NCT02296255·832 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)